Manifest Technologies emerged from stealth with strategic investors and prepares for the next development stage of AI-powered precision neuroscience.
Manifest Technologies emerged from stealth with strategic investors and prepares for the next development stage of AI-powered precision neuroscience.
03/28/24, 3:34 PM
Location
new havenIndustry
machine learning
artificial intelligence
biotechnology
health care
Investors
Kaleida Capital, Johnson & Johnson, Nih Funded Research At Yale
Manifest Technologies unveiled the company after completing its initial funding and partnership with a top five global pharmaceutical company. The company aims to transform how CNS treatments are developed and delivered in the clinic, leveraging computational neuroscience and AI to enable a true precision medicine approach to mental illness and neurodegenerative diseases like Alzheimer’s Disease and Parkinson’s Disease.
Company Info
Location
new haven, kentucky, united states
Additional Info
Manifest Technologies is transforming CNS health through AI-powered precision neuroscience and computational neuroimaging. Manifest was founded in 2021 by a group of leading scientists who have created the NAIO™ (Neuroscience and Artificial Intelligence Optimized) platform. NAIO™ incorporates proprietary software and several patents under an exclusive license from Yale University. Manifest is building a suite of specific applications out of the NAIO™ platform to meet the needs of both pharmaceutical CNS R&D and health care providers.